Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Evaluation of Repotrectinib's Anti-MM Effects in Combination with Bortezomib, Carfilzomib, Cyclophosphamide, and Dexamethasone in Vitro and Ex Vivo

Haiming Chen, Eric Souther, Mingjie Li, Marissa-Skye Goldwater, Stacy Behare, Ava Hekmati, Huixin Yu, Isabella Nassir, Ariella Nassir, Ning Xu, James R. Berenson

Blood (2022) 140 (Supplement 1): 4213–4214.

https://doi.org/10.1182/blood-2022-169890

Published: 2022

Journal Articles

Repotrectinib Alone and in Combination with Immunomodulatory Drugs Exhibits Potent Anti-Multiple Myeloma Activity

Haiming Chen, Eric Souther, Mingjie Li, Marissa-Skye Goldwater, Stacy Behare, Ava Hekmati, Huixin Yu, Isabella Nassir, Ariella Nassir, Ning Xu, James R. Berenson

Blood (2022) 140 (Supplement 1): 12460–12461.

https://doi.org/10.1182/blood-2022-167862

Published: 2022

Journal Articles

Ruxolitinib Enhances Anti-MM Function of Cytotoxic T-Cells By Upregulating IFNγ and Gzmb

Haiming Chen, Mingjie Li, Marissa-Skye Goldwater, Stacy Behare, Ava Hekmati, Huixin Yu, Isabella Nassir, Ariella Nassir, Charles David Deighton, Ning Xu, James R. Berenson

Blood (2022) 140 (Supplement 1): 12459.

https://doi.org/10.1182/blood-2022-167768

Published: 2022

Journal Articles

The JAK Inhibitor Pacritinib Suppresses the Checkpoint Proteins Pvrig and Tigit Expression on T Cells in Multiple Myeloma Patients

Ning Xu, Mingjie Li, Marissa-Skye Goldwater, Stacy Behare, Ava Hekmati, Huixin Yu, Isabella Nassir, Ariella Nassir, Charles David Deighton, Haiming Chen, James R. Berenson

Blood (2022) 140 (Supplement 1): 12458.

https://doi.org/10.1182/blood-2022-167320

Published: 2022

Journal Articles

Sars-Cov-2 Antibody Decay Monitoring in mRNA Vaccinated Multiple Myeloma Patients

Samuel D. Stampfer, Marissa-Skye Goldwater, Bernard Sean S. Regidor, Scott Kristian Jew, Sean Elliott Bujarski, Haiming Chen, David Yashar, Ning Xu, Mingjie Li, Tracy Green, Eddie Fung, Elias Aquino, Regina Swift, Shahrooz Eshaghian, Aaron Feinstein, James R. Berenson

Blood (2021) 138 (Supplement 1): 2712.

https://doi.org/10.1182/blood-2021-154287

Published: 2021

Journal Articles

Dominant Expression of PVRIG and TIGIT Inhibitory Pathways in Bone Marrow of Multiple Myeloma Patients

Masha Frenkel, Zoya Alteber, Ning Xu, Mingjie Li, Haiming Chen, Gady Cojocaru, James R. Berenson, Eran Ophir

Blood (2021) 138 (Supplement 1): 4717.

https://doi.org/10.1182/blood-2021-148052

Published: 2021

Journal Articles

Anti-Myeloma Effects of Panobinostat in Combination with Duvelisib

Haiming Chen, Mingjie Li, Marissa Goldwater, Stacy Behare, Jasmin Cao, Cara Wallingford, Ava Hekmati, Rocky Levin, Eric Souther, Ning Xu, James R. Berenson

Blood (2021) 138 (Supplement 1): 4709.

https://doi.org/10.1182/blood-2021-153983

Published: 2021

Journal Articles

Baseline and Increases in Serum B-Cell Maturation Antigen Levels Rapidly Indicate Changes in Clinical Status Among Relapsed/Refractory Multiple Myeloma Patients Undergoing New Treatments

Sean Bujarski, BA, Kyle Udd, BA, Camilia Soof, BS, Tanya M. Spektor, PhD, Tahmineh Safaie, Haiming Chen, MD PhD, Mingjie Li, BS, Eric Sanchez, BA, Joshua Stern, Cathy S. Wang, BS, Ning Xu, PhD, Marsiye Emamy-Sadr, Regina Swift, Ashkon Rahbari, Saurabh Patil, BS, Eric Souther, James R. Berenson, MD

Blood (2019) 134 (Supplement_1): 1786.

https://doi.org/10.1182/blood-2019-132012

Published: 2019

Journal Articles

Ruxolitinib Reverses Checkpoint Inhibition By Downregulating PD-L1 and PD-L2 Expression on Both Tumor and Stromal Cells in Multiple Myeloma

Haiming Chen, MD PhD, Mingjie Li, BS, Eric Sanchez, BA, Nicole Ng, BS, Erin Yu, BS, Sean Bujarski, BA, Zhengyi Yin, Tara Hekmati, Dylan Field, Jasper Wang, Isabella Nassir, Janna Yu, Justin Huang, David Daniely, Cathy S. Wang, BS, Ning Xu, PhD, James R. Berenson, MD

Blood (2019) 134 (Supplement_1): 4402.

https://doi.org/10.1182/blood-2019-130888

Published: 2019

Journal Articles

The JAK1/2 Inhibitor Ruxolitinib Downregulates CXCL12 Secretion from Bone Marrow Stromal Cells and M2 Macrophage Polarization in Multiple Myeloma

Haiming Chen, MD PhD, Mingjie Li, BS, Eric Sanchez, BA, Nicole Ng, BS, Erin Yu, BS, Sean Bujarski, BA, Zhengyi Yin, Tara Hekmati, Dylan Field, Jasper Wang, Isabella Nassir, Justin Huang, David Daniely, Cathy S. Wang, BS, Ning Xu, PhD, James R. Berenson, MD

Blood (2019) 134 (Supplement_1): 4352.

https://doi.org/10.1182/blood-2019-131324

Published: 2019

Journal Articles

The JAK1/2 Inhibitor Ruxolitinib Downregulates the Immune Checkpoint Protein B7-H3 in Multiple Myeloma

Ning Xu, PhD, Nicole Ng, BS, Mingjie Li, BS, Erin Yu, BS, Eric Sanchez, BA, Sean Bujarski, BA, Zhengyi Yin, Tara Hekmati, Dylan Field, Jasper Wang, Isabella Nassir, Janna Yu, Justin Huang, David Daniely, Cathy S. Wang, BS, Haiming Chen, MD PhD, James R. Berenson, MD

Blood (2019) 134 (Supplement_1): 1824.

https://doi.org/10.1182/blood-2019-131047

Published: 2019

Journal Articles

Differential Expression of CD49f Discriminates the Independently Emerged Hematopoietic Stem Cells and Erythroid-Biased Progenitors

Ai-Ning Xu, Dan Liu, Yu-Ting Dai, Fan Zhang, Jian Shen, MSc, Cheng-Long Hu, Chun-Hui Xu, Yuan-Liang Zhang, Yin-Yin Xie, Qiu-Hua Huang, Peng-Fei Xu, Lan Wang, Lin Cheng, Jinyan Huang, PhD, Zhu Chen, PhD, Sai-Juan Chen, PhD, Xiao-Jian Sun, PhD

Blood (2019) 134 (Supplement_1): 3700.

https://doi.org/10.1182/blood-2019-130429

Published: 2019

Journal Articles

The JAK Inhibitor Blocks PD-L1, PD-L2 and CD44 Expression in Multiple Myeloma (MM) and Sensitizes MM Cells to Lenalidomide and Steroids

Haiming Chen, MD PhD, Mingjie Li, BS, Eric Sanchez, BA, Camilia M. Soof, BS, Sean Bujarski, BA, Nicole Ng, Jasmin Cao, BS, Tara Hekmati, BS, Edward J Tanenbaum, BS, Brian Zahab, Cathy S. Wang, BS, George Y Tang, PhD, Ning Xu, PhD, James R Berenson, MD

Blood (2018) 132 (Supplement 1): 1910.

https://doi.org/10.1182/blood-2018-99-119099

Published: 2018

Journal Articles

Angiogenesis Induced By Aminoacyl-tRNA Synthetase Deficiency Is Dependent on Amino Acid Response (AAR) but Not Unfolded Protein Response (UPR) Pathways

Fan Zhang, Yi Chen, Yi Jin, Chun-Hui Xu, Dian-Jia Liu, Ai-Ning Xu, Yuan-Liang Zhang, Yin-Yin Xie, Jing-Yi Shi, Lan Wang, MD, Qiu-Hua Huang, Zhu Chen, Sai-Juan Chen, Xiao-Jian Sun, PhD

Blood (2018) 132 (Supplement 1): 77.

https://doi.org/10.1182/blood-2018-99-117909

Published: 2018

Journal Articles

Stem Cell Approach to Generate Chimeric Antigen Receptor Modified Immune Effector Cells to Treat Cancer

Alla Dolnikov, PhD, Shen Sylvie, PhD, Ning Xu, PhD, Tracey O'Brien, MD

Blood (2014) 124 (21): 2437.

https://doi.org/10.1182/blood.V124.21.2437.2437

Published: 2014

Journal Articles

5-Aza-2'-Deoxycytidine Promotes Cytotoxic Effect of CART-Cells on Leukaemia Cells

Alla Dolnikov, PhD, Swapna Rossi, Ning Xu, PhD, Guy Klamer, PhD, Sylvie Shen, PhD, Kenneth P. Micklethwaite, MD PhD, Richard B Lock, PhD, Tracey O'Brien, MD

Blood (2014) 124 (21): 5812.

https://doi.org/10.1182/blood.V124.21.5812.5812

Published: 2014

Journal Articles

Identifying the Factors Modulating the Efficacy of CAR-T Cell Therapy

Alla Dolnikov, PhD, Guy Klamer, PhD, Arjanna Chitranjan, Ning Xu, PhD, Sylvie Shen, PhD, Kenneth P. Micklethwaite, MD PhD, Richard B. Lock, PhD, Tracey O'Brien, MD

Blood (2014) 124 (21): 5813.

https://doi.org/10.1182/blood.V124.21.5813.5813

Published: 2014

Journal Articles

GSK3β Inhibition Promotes T Cell Reconstitution and Preserves Naive T Cell Phenotype in Bone Marrow Reconstituted Mice

Shen Sylvie, PhD, Ning Xu, PhD, Guy Klamer, Tracey O'Brien, MD, Alla Dolnikov, PhD

Blood (2012) 120 (21): 1890.

https://doi.org/10.1182/blood.V120.21.1890.1890

Published: 2012

NARROW

Evaluation of Repotrectinib's Anti-MM Effects in Combination with Bortezomib, Carfilzomib, Cyclophosphamide, and Dexamethasone in Vitro and Ex Vivo

Repotrectinib Alone and in Combination with Immunomodulatory Drugs Exhibits Potent Anti-Multiple Myeloma Activity

Ruxolitinib Enhances Anti-MM Function of Cytotoxic T-Cells By Upregulating IFNγ and Gzmb

The JAK Inhibitor Pacritinib Suppresses the Checkpoint Proteins Pvrig and Tigit Expression on T Cells in Multiple Myeloma Patients

Sars-Cov-2 Antibody Decay Monitoring in mRNA Vaccinated Multiple Myeloma Patients

Dominant Expression of PVRIG and TIGIT Inhibitory Pathways in Bone Marrow of Multiple Myeloma Patients

Anti-Myeloma Effects of Panobinostat in Combination with Duvelisib

Baseline and Increases in Serum B-Cell Maturation Antigen Levels Rapidly Indicate Changes in Clinical Status Among Relapsed/Refractory Multiple Myeloma Patients Undergoing New Treatments

Ruxolitinib Reverses Checkpoint Inhibition By Downregulating PD-L1 and PD-L2 Expression on Both Tumor and Stromal Cells in Multiple Myeloma

The JAK1/2 Inhibitor Ruxolitinib Downregulates CXCL12 Secretion from Bone Marrow Stromal Cells and M2 Macrophage Polarization in Multiple Myeloma

The JAK1/2 Inhibitor Ruxolitinib Downregulates the Immune Checkpoint Protein B7-H3 in Multiple Myeloma

Differential Expression of CD49f Discriminates the Independently Emerged Hematopoietic Stem Cells and Erythroid-Biased Progenitors

The JAK Inhibitor Blocks PD-L1, PD-L2 and CD44 Expression in Multiple Myeloma (MM) and Sensitizes MM Cells to Lenalidomide and Steroids

Angiogenesis Induced By Aminoacyl-tRNA Synthetase Deficiency Is Dependent on Amino Acid Response (AAR) but Not Unfolded Protein Response (UPR) Pathways

Stem Cell Approach to Generate Chimeric Antigen Receptor Modified Immune Effector Cells to Treat Cancer

5-Aza-2'-Deoxycytidine Promotes Cytotoxic Effect of CART-Cells on Leukaemia Cells

Identifying the Factors Modulating the Efficacy of CAR-T Cell Therapy

GSK3β Inhibition Promotes T Cell Reconstitution and Preserves Naive T Cell Phenotype in Bone Marrow Reconstituted Mice

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only